Organ-on-Chip Market Key Players| Emulate, AxoSim Technologies LLC, CN Bio innovations, Hurel Corporation, Hepregen, Insphero, Mimetas, Nortis

A Comprehensive research study conducted by KD Market Insights on " Organ-on-Chip Market by Type (Heart-on-chip, Human-on-chip, Intestine-on-chip, Kidney-on-chip, Liver-on-chip, and Lung-on-chip) - Global Opportunity Analysis and Industry Forecast, 2017-2023" report offers extensive and highly detailed historical, current and future market trends in the global and regional/market. The Organ-on-Chip Market report includes market size, growth drivers, barriers, opportunities, trends and other information which helps to find new opportunities in this market for the growth of the business through new technologies and developments.

Organ-on-chip a multichannel 3D micro-fluidic cell culture device, which simulates activities, mechanisms, and physiological responses of human organs. This chip develops a narrow channel for the blood and air flow in organs including lung, gut, liver, heart, and others. This devices is developed on a microchip that contains continuously perfused chambers colonized by living cells arranged to stimulate tissue- and organ-level physiology. It is used to nurture internal organs with the help of silicone.

The growth of the global organ-on-chip market is driven by increase in its applications in the healthcare sector, rise in demand for drug screening, and high demand for lung-based organ culture & kidney applications. However, high cost and nascent stage in R&D restrict the market growth. Conversely, increase in research activities on organ-on-chip is expected to offer ample opportunities to the key players.

Request for Sample @ https://www.kdmarketinsights.com/sample/4347 
 
The global organ-on-chip market is segmented on the basis of type and geography. Depending on type, the market is divided into heart-on-chip, human-on-chip, intestine-on-chip, kidney-on-chip, liver-on-chip, and lungs-on-chip. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Emulate, AxoSim Technologies LLC, CN Bio innovations, Hurel Corporation, Hepregen, Insphero, Mimetas, Nortis, Organovo, and Tara Biosystems are some of the major key players operating in the global organ-on-chip market.

KEY BENEFITS FOR STAKEHOLDERS
- This study includes the analytical depiction of the global organ-on-chip market along with current trends and future estimations to determine the imminent investment pockets.
- The report presents information regarding key drivers, restraints, and opportunities.
- The current market is quantitatively analyzed from 2016 to 2023 to highlight the financial competency of the industry.
- Porter’s Five Forces analysis illustrates the potency of the buyers and suppliers in the industry.

KEY MARKET SEGMENTS
By Type
- Heart-on-chip
- Human-on-chip
- Intestine-on-chip
- Kidney-on-chip
- Liver-on-chip
- Lung-on-chip

By Region
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Latin America
- Middle East
- Africa

Browse Full Report with TOC @ https://www.kdmarketinsights.com/product/organ-on-chip-market-amr
Table of Contents:

CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. RESEARCH METHODOLOGY
1.3.1. Primary research
1.3.2. Secondary research
1.3.3. Analyst tools and models
1.3.4. Market segmentation

CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.2.3. Top impacting factors
3.2.3.1. Surge in application of organ-on-chip devices in the healthcare sector
3.2.3.2. Increase in demand for organ-on-chip in drug screening
3.2.3.3. Rise in demand for lung- & kidney -based organ culture devices
3.2.3.4. High cost of organ-on-chip devices
3.2.3.5. Nascent stage in R&D pertaining to OOCs
3.2.3.6. Increase in research activities on organ-on-chip devices
3.3. PORTERS FIVE FORCES
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry
3.4. MARKET PLAYER POSITIONING, 2016
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Surge in application of organ-on-chip devices in the healthcare sector
3.5.1.2. Increase in demand for organ-on-chips in drug screening
3.5.1.3. Rise in demand for lung- & kidney-based organ culture devices
3.5.2. Restraints
3.5.2.1. High costs of organ-on-chip devices
3.5.2.2. Nascent stage in R&D pertaining to OOCs
3.5.3. Opportunity
3.5.3.1. Increase in research activities on organ-on-chip devices

CHAPTER 4 ORGAN-ON-CHIP MARKET, BY TYPE
4.1. OVERVIEW
4.2. HEART-ON-CHIP
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.3. HUMAN-ON-CHIP
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.4. INTESTINE-ON-CHIP
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.5. KIDNEY-ON-CHIP
4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.6. LIVER-ON-CHIP
4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast
4.7. LUNG-ON-CHIP
4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast

CHAPTER 5 ORGAN-ON-CHIP MARKET, BY GEOGRAPHY
5.1. OVERVIEW
5.2. NORTH AMERICA
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast, by type
5.2.4. Market size and forecast, by country
5.2.5. U.S.
5.2.5.1. Market size and forecast
5.2.6. Canada
5.2.6.1. Market size and forecast
5.2.7. Mexico
5.2.7.1. Market size and forecast
5.3. EUROPE
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast, by type
5.3.4. Market size and forecast, by country
5.3.5. UK
5.3.5.1. Market size and forecast
5.3.6. Germany
5.3.6.1. Market size and forecast
5.3.7. France
5.3.7.1. Market size and forecast
5.3.8. Rest of Europe
5.3.8.1. Market size and forecast
5.4. ASIA-PACIFIC
5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast, by type
5.4.4. Market size and forecast, by country
5.4.5. China
5.4.5.1. Market size and forecast
5.4.6. Japan
5.4.6.1. Market size and forecast
5.4.7. India
5.4.7.1. Market size and forecast
5.4.8. Australia
5.4.8.1. Market size and forecast
5.4.9. Rest of Asia-Pacific
5.4.9.1. Market size and forecast
5.5. LAMEA
5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast, by type
5.5.4. Market size and forecast, by region
5.5.5. Latin America
5.5.5.1. Market size and forecast
5.5.6. Middle East
5.5.6.1. Market size and forecast
5.5.7. Africa
5.5.7.1. Market size and forecast

CHAPTER 6 COMPANY PROFILES
6.1. AXOSIM TECHNOLOGIES LLC
6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio
6.2. CN INNOVATIONS HOLDINGS LIMITED (CN BIO INNOVATIONS)
6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product portfolio
6.2.5. Key strategic moves and developments
6.3. EMULATE, INC.
6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Product portfolio
6.3.5. Key strategic moves and developments
6.4. ASCENDANCE BIOTECHNOLOGY, INC.
6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Product portfolio
6.4.5. Key strategic moves and developments
6.5. HUREL CORPORATION
6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.5.4. Product portfolio
6.5.5. Key strategic moves and developments
6.6. INSPHERO AG
6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Product portfolio
6.6.5. Key strategic moves and developments
6.7. MIMETAS B.V.
6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.7.5. Key strategic moves and developments
6.8. NORTIS INC.
6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.8.4. Product portfolio
6.8.5. Key strategic moves and developments
6.9. ORGANOVO HOLDINGS, INC.
6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.9.5. Business performance
6.9.6. Key strategic moves and developments
Continue….
 
Check for Discount @ https://www.kdmarketinsights.com/discount/4347 

Contact Us:
 
KD Market Insights
90 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: info@kdmarketinsights.com 
Website: www.kdmarketinsights.com 
Read More News: https://consumersgoods745245330.wordpress.com/
https://ictindustry9.blogspot.com/ 

About Us:

KD Market Insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends. Our in-house research experts have a wealth of knowledge in their respective domains. With KD Market Research, you always have the choice of getting customized report free of cost (up to 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision.
Our clients list includes various Fortune 500 companies and leading advisory firms.

This release was published on openPR.